
ORTHOPEDIATRICS CORP
KIDSNASDAQTrading Snapshot
- Day Range
- $24.54 β $24.79
- 52-Week Range
- $14.42 β $24.56
- Volume
- $3.08B
- Avg Volume
- $3.07B
- Shares Outstanding
- 25.7M
- Next Earnings
- Sep 23, 2026
Fundamentals Snapshot
- Annual Revenue
- $236M
- Last Q Revenue
- $71M
- P/E Ratio
- -14.4
- P/S Ratio
- 2.5x
- EPS (TTM)
- $-1.66
- Dividend Yield
- 0.00%
Why Investors Own KIDS
- βHigh-growth profile β revenue up +50.5% YoY with expanding US Equity exposure.
- βHealthy economics β 59% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ORTHOPEDIATRICS CORP
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ORTHOPEDIATRICS CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift KIDS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ORTHOPEDIATRICS CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.